Cholera Vaccine Market 2026 – Status and Development, Average Product Price and Market Shares of Key Players

Increasing prevalence of chronic disease is expanding the growth of the Cholera Vaccines Market

HYDERABAD, TELANGANA, INDIA, November 28, 2022 /EINPresswire.com/ -- Cholera Vaccine Market size is forecast to reach $239.6 million by 2026, growing at a CAGR of 7.9% during the forecast period 2021-2026. Cholera is caused via the consumption of contaminated food and water by Vibrio Cholerae. It leads to dehydration which in turn may lead to death if not attended properly. It is anticipated to be a global threat to public health that lacks social development and so it is essential to control cholera. Various products that are used for controlling cholera includes Dukoral, Euvichol, Vaxchora, and Shanchol among others. According to international organizations such as WHO, vaccinations have proved to be one of the best methods to treat cholera and has recommended that cholera vaccines should be taken at least 2 weeks gap between the doses. Rising prevalence of chronic diseases and growing awareness on immunization are the major factors driving the growth of the market. Increasing focus of the key pharmaceutical players to develop vaccines and rising government focus on immunization programs is set to further enhance the overall market development of the Cholera Vaccine Market for the period 2021-2026.

Click here to browse the complete report summary:
https://www.industryarc.com/Research/Cholera-Vaccine-Market-Research-506916

Key Takeaways

Asia-Pacific dominated the Cholera Vaccine Market in 2020 owing to the increase in the prevalence of cholera disease and rise in the awareness of immunization. The Cholera Vaccine Market scope for different regions will be provided in the final report.

Favorable medical reimbursement policies and growing adoption of combination vaccines in prevention strategies by government are likely to aid the market growth of the Cholera Vaccine Market report.

Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Cholera Vaccine Market report.

Lack of proper sanitation and high cost associated with the development of vaccines is poised to create the hurdles for the Cholera Vaccine Market.

Interested in knowing more relevant information? Click here:
https://www.industryarc.com/pdfdownload.php?id=506916

Segmental Analysis:

Cholera Vaccine Market Segment Analysis – By Product Type: Dukoral held the largest share in the Cholera Vaccine Market in 2020 and is estimated to grow at a CAGR 7.3% during the forecast period 2021-2026. This is attributed to the established stockpile by WHO and it is the only vaccine that provides protection caused by heat toxin producing E. coli. Dukoral offers benefits such as minimum adverse effects and single dose live attenuated immunization. FDA approved single dose Vaxchora that is indicated for use in adult and is carried out in U.S. and Australia where 90% of adults vaccinated and developed antibodies that provides immunity against the disease. Vaxchora is estimated to register the highest CAGR over the period 2021-2026.

Cholera Vaccine Market Segment Analysis – By End Users: Hospital held the largest share in the Cholera Vaccine Market in 2020 and is estimated to grow at a CAGR 8.1% during the forecast period 2021-2026. This is attributed to the fact that it offers minimally invasive procedures for cholera along with the high end technological products. Growing demand for immunization, availability of highly skilled and qualified medical professionals in the hospitals along with the rising incidences of cholera is increasing the demand of the hospitals.

Cholera Vaccine Market Segment Analysis – By Geography: Asia Pacific dominated the Cholera Vaccine Market with a major share of 36.5% in 2020. This is attributed to the rising incidences of cholera and rising awareness about immunization. Growing healthcare expenditures, favorable reimbursement policies, and presence of key players is also increasing the growth of the market in this region. However, North America is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to the lack of proper sanitation and consumption of contaminated food. Rising government focus on immunization programs and growing awareness about immunization is also increasing the growth of the market in this region.

Competitive Landscape:

The top 5 players in the Cholera Vaccine Market Industry are -

1. Valneva SE,
2. Sanofi,
3. Johnson & Johnson,
4. Celldex Therapeutics Inc.,
5. Merck & Co

Click on the following link to buy the Cholera Vaccine Market Report:
https://www.industryarc.com/reports/request-quote?id=506916

Why Choose IndustryARC?

IndustryARC is one of the leading market research and consulting firms in the world. It produces over 500 unique market reports annually. If you are looking for a detailed overview of a particular market, you can simply connect with the team at IndustryARC. You can not only buy your preferred market report from the website, but also get personalized assistance on specific reports.

Related Reports:

A. Veterinary Vaccines Market
https://www.industryarc.com/Report/9591/veterinary-vaccines-market.html

B. Cholera Treatment Market
https://www.industryarc.com/Report/16860/cholera-treatment-market.html

Contact Us:
Mr. Venkat Reddy
IndustryARC
Email: venkat@industryarc.com, sales@industryarc.com
USA: (+1) 970-236-3677, (+1) 815-656-4596
IND: (+91) 40-485-49062

Venkat Reddy
IndustryARC
+1 614-588-8538
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn